The release of the Osteoporosis Canada 2023 Clinical Practice Guideline will support Canadian healthcare providers in providing the most current evidence-based information for patient centred care to optimise skeletal health […]

Community Backbone Award Submission Form Award Criteria The Community Backbone Award is presented annually to individuals who: Are considered integral to the organization by proving their commitment to the mission […]

Financial Statements Osteoporosis Canada is committed to being accountable, fiscally responsible and transparent to our supporters, donors and volunteers. Current Statements 2023 Audited Financial Statements Download Past Statements 2022 Audited […]

Dr. Rowena Ridout is the new chair of Osteoporosis Canada’s Scientific Advisory Council. Rowena has been involved with Osteoporosis Canada since 2010 as an active member of the Scientific Advisory Council.  […]

We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]

We are aware of a recent Food and Drug Administration (FDA) publication that reports on the association between use of zoledronic acid (Aclasta) and renal impairment. 1 We recognize that […]

MEET THE CMC FACULTY Dr. Cathy Craven University of Toronto  Toronto, ON Cathy Craven is the Toronto Rehabilitation Institute/ University of Toronto Chair in Spinal Cord Injury (SCI) Rehabilitation, Professor […]

CMC 2023 The Canadian Musculoskeletal Conference (CMC) hosted by Osteoporosis Canada is November 23 and 24, 2023. Led by national and international experts in osteoporosis, this dynamic conference will offer […]

Available Volunteer Opportunities Call for Nominations – Board of Directors Osteoporosis Canada (OC), a registered charity, is the only national organization serving people who have, or are at risk for, […]